George and colleagues demonstrate the use of the Michigan Urological Surgery Improvement Collaborative (MUSIC) template to perform a freehand transperineal prostate biopsy using the PrecisionPoint Transperineal Access System.
The video above, as well as videos from Amir H. Lebastchi, MD, Luke O’Connor, PhD, and Peter A. Pinto, MD; and Andre L. Abreu, MD, illustrate techniques for performing transperineal prostate biopsy. Commentary on the videos is provided by Lebastchi, clinical fellow in urologic oncology, Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.
Lebatschi: George and colleagues demonstrate the use of the Michigan Urological Surgery Improvement Collaborative (MUSIC) template to perform a freehand transperineal prostate biopsy using the PrecisionPoint Transperineal Access System. The University of Michigan group utilizes the innovative PrecisionPoint device, which clamps onto the ultrasound probe. This keeps the biopsy needle in line with the sagittal imaging array and facilitates guidance of the needle toward the biopsy targets. This group uses the MUSIC template, which is a modified 12-core transperineal template biopsy that employs only two access points (one on each side of the prostate). Throughout the procedure, the height of the needle can be adjusted in the carriage to ensure the appropriate level of entry into the prostate. Following the procedure, pressure is applied to the two entry points to achieve hemostasis. The puncture sites are dressed with antibiotic ointment and gauze.
George is assistant professor of urology, University of Michigan, Ann Arbor.
'Y'tube Section Editor James M. Hotaling, MD, MS, is assistant professor of surgery (urology) at the Center for Reconstructive Urology and Men's Health, University of Utah, Salt Lake City.
Targeted radiation plus systemic therapy combo shows promise in mHSPC
March 18th 2024"The combination of highly potent systemic therapy and targeted radiation has shown impressive results in maintaining low PSA levels after testosterone recovery, offering hope for improved outcomes in these patients, but further studies are still needed to determine the best regimen," says Amar U. Kishan, MD.
Agents show potential to bolster precision medicine in prostate cancer
March 12th 2024"[Now that] we have entered the era of precision and personalized medicine, well-designed clinical trials are needed to address selected focused questions regarding optimal therapy sequencing,” says Maha H.A. Hussain, MBChB.